The Huntsman Cancer Institute (HCI) is a designated research unit of the University of Utah. It was formed in July 1994, from the previous, NCI-designate Utah Regional Cancer Center, with major funding provided in late 1995 by the Jon M. Huntsman family, through the Huntsman Cancer Foundation. The mission of the HCI is the translation of molecular and genetic discoveries in the mechanisms of carcinogenesis into clinically effective diagnostics and therapies. The Institute's primary focus on understanding and intervening in the earliest events in the carcinogenesis pathways, at the level of the cancer precursor cell, leads to a strong emphasis on identifying the inherited components of cancer predisposition, as these components are often among the earliest steps in the carcinogenesis pathways. This orientation stem's from the University's history in the development and use of molecular genetic tools for mapping of human disease genes, in particular the genes that predispose to cancer. The Cancer Center is organized into six programs; three basic science programs-Cell Response and Regulation, Molecular Pharmacology, and Nuclear Control of Cell Growth and Differentiation and three disease-focused programs-Brain, Colon and Hematology. Fourteen research resource facilities service these programs; seven of these are new facilities established since the last competitive renewal. In this application, we are requesting funds in the amount of $1.2 million, 46 percent of which will support shared resource facilities, 26 percent professional and administrative personnel, and 25 percent for development. The leadership of the HCI and the University of Utah are committed to the efforts of the Cancer Center. Raymond L. White, Ph.D., is the Executive Director of the HCI and the Principal Investigator of the Cancer Center Support Grant. His laboratory has been heavily involved in studies of genes that predispose to cancer for nearly two decades. Furthermore, the ice President and Dean of the Health Sciences Center at the University provides strong institutional support in the form of space and core resources for the institute's scientific endeavors.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA042014-14
Application #
6375744
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ptak, Krzysztof
Project Start
1986-07-01
Project End
2004-04-30
Budget Start
2001-08-03
Budget End
2002-04-30
Support Year
14
Fiscal Year
2001
Total Cost
$1,238,364
Indirect Cost
Name
University of Utah
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Vahrenkamp, Jeffery M; Yang, Chieh-Hsiang; Rodriguez, Adriana C et al. (2018) Clinical and Genomic Crosstalk between Glucocorticoid Receptor and Estrogen Receptor ? In Endometrial Cancer. Cell Rep 22:2995-3005
Gupta, Sumati; Albertson, Daniel; Gaston, David et al. (2018) Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)-Deficient Carcinomas of the Urinary System. Clin Genitourin Cancer 16:e373-e382
Yazdimamaghani, Mostafa; Moos, Philip J; Ghandehari, Hamidreza (2018) Global gene expression analysis of macrophage response induced by nonporous and porous silica nanoparticles. Nanomedicine 14:533-545
Al-Agha, Abdulmoein Eid; Ahmed, Ihab Abdulhamed; Nuebel, Esther et al. (2018) Primary Ovarian Insufficiency and Azoospermia in Carriers of a Homozygous PSMC3IP Stop Gain Mutation. J Clin Endocrinol Metab 103:555-563
Petersen, Jenna; Koptiuch, Cathryn; Wu, Yelena P et al. (2018) Patterns of family communication and preferred resources for sharing information among families with a Lynch syndrome diagnosis. Patient Educ Couns 101:2011-2017
Flack, Caralyn E; Parkinson, John S (2018) A zipped-helix cap potentiates HAMP domain control of chemoreceptor signaling. Proc Natl Acad Sci U S A 115:E3519-E3528
Pishas, Kathleen I; Drenberg, Christina D; Taslim, Cenny et al. (2018) Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response. Mol Cancer Ther 17:1902-1916
Blackburn, Brenna E; Ganz, Patricia A; Rowe, Kerry et al. (2018) Reproductive and gynecological complication risks among thyroid cancer survivors. J Cancer Surviv 12:702-711
Wu, Yelena P; Aspinwall, Lisa G; Nagelhout, Elizabeth et al. (2018) Development of an Educational Program Integrating Concepts of Genetic Risk and Preventive Strategies for Children with a Family History of Melanoma. J Cancer Educ 33:774-781
Kim, Hyung-Seok; McKnite, Autumn; Xie, Yuanyuan et al. (2018) Fibronectin type III and intracellular domains of Toll-like receptor 4 interactor with leucine-rich repeats (Tril) are required for developmental signaling. Mol Biol Cell 29:523-531

Showing the most recent 10 out of 1193 publications